Exactech Q2 Revenue $67.3 Million On Continuing Strong Extremities Revenue; Q2 Net Income $4.8 Million; Diluted EPS $0.33
Gainesville, Fla. (July 27, 2017) – Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that…
View Story